Ascendis Pharma Lands Long-Awaited FDA Drug Approval in Rare Hormone Deficiency
Patients with hypoparathyroidism have been clamoring for an alternative to a Takeda Pharmaceutical therapy set to cease production by the end of the year, leaving them with no drug treatments....